Stock News

Thomas Story & Son Has Decreased Amgen (AMGN) Position By $1.40 Million; 9 Analysts Bullish IBERIABANK (IBKC)

IBERIABANK Corporation (NASDAQ:IBKC) Logo

Among 14 analysts covering IberiaBank (NASDAQ:IBKC), 9 have Buy rating, 0 Sell and 5 Hold. Therefore 64% are positive. IberiaBank had 57 analyst reports since August 25, 2015 according to SRatingsIntel. The company was maintained on Thursday, October 5 by Robert W. Baird. The company was upgraded on Tuesday, January 19 by Hovde Group. Stephens maintained the shares of IBKC in report on Monday, June 5 with “Buy” rating. Piper Jaffray maintained IBERIABANK Corporation (NASDAQ:IBKC) rating on Friday, July 21. Piper Jaffray has “Hold” rating and $8900 target. The stock of IBERIABANK Corporation (NASDAQ:IBKC) has “Buy” rating given on Friday, April 20 by SunTrust. As per Monday, January 29, the company rating was maintained by Piper Jaffray. JMP Securities initiated IBERIABANK Corporation (NASDAQ:IBKC) on Thursday, February 2 with “Mkt Perform” rating. The rating was maintained by Jefferies on Friday, June 9 with “Hold”. The stock of IBERIABANK Corporation (NASDAQ:IBKC) earned “Hold” rating by Robert W. Baird on Monday, October 23. The rating was upgraded by SunTrust to “Buy” on Tuesday, November 28. See IBERIABANK Corporation (NASDAQ:IBKC) latest ratings:

24/04/2018 Broker: Jefferies Rating: Buy New Target: $93.0000 Maintain
23/04/2018 Broker: Piper Jaffray Rating: Buy New Target: $92.0000 Maintain
20/04/2018 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $92.0000 Maintain
20/04/2018 Broker: Sandler O’Neill Rating: Buy New Target: $90.0000 Maintain
20/04/2018 Broker: Stephens Rating: Hold New Target: $83.0000 Maintain
20/04/2018 Broker: SunTrust Rating: Buy New Target: $93.0000 Maintain
26/02/2018 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $99.0 Maintain
09/02/2018 Broker: Hovde Group Rating: Hold New Target: $85.0 Maintain
29/01/2018 Broker: Stephens Rating: Hold New Target: $90.0 Maintain
29/01/2018 Broker: Piper Jaffray Rating: Buy New Target: $95.0 Maintain

Thomas Story & Son Llc decreased Amgen Inc (AMGN) stake by 84.3% reported in 2017Q4 SEC filing. Thomas Story & Son Llc sold 8,057 shares as Amgen Inc (AMGN)’s stock declined 2.99%. The Thomas Story & Son Llc holds 1,500 shares with $261,000 value, down from 9,557 last quarter. Amgen Inc now has $118.26 billion valuation. The stock increased 0.71% or $1.26 during the last trading session, reaching $177.56. About 320,781 shares traded. Amgen Inc. (NASDAQ:AMGN) has risen 3.78% since May 21, 2017 and is uptrending. It has underperformed by 7.77% the S&P500.

IBERIABANK Corporation operates as the bank holding firm for IBERIABANK that provides commercial and retail banking services and products in the United States. The company has market cap of $4.57 billion. It offers various commercial, consumer, mortgage, and private banking services and products; cash management services; deposit and annuity products; and brokerage services, as well as sells variable annuities. It has a 31.13 P/E ratio. The firm also provides various title insurance and loan closing services for residential and commercial customers; one-to-four family residential mortgage loans; equity research, institutional sales and trading, and corporate finance services; and wealth management and trust advisory services to high net worth individuals, pension funds, firms, and trusts, as well as invests in a commercial rental property and purchased tax credits.

The stock increased 1.51% or $1.2 during the last trading session, reaching $80.65. About 85,440 shares traded. IBERIABANK Corporation (NASDAQ:IBKC) has risen 2.51% since May 21, 2017 and is uptrending. It has underperformed by 9.04% the S&P500.

More notable recent IBERIABANK Corporation (NASDAQ:IBKC) news were published by: Seekingalpha.com which released: “IBERIABANK announces branch closures and consolidations” on May 21, 2018, also Streetinsider.com with their article: “IBERIABANK Corp. (IBKC) to Close or Consolidate 22 Branches” published on May 18, 2018, Streetinsider.com published: “IBERIABANK Corp. (IBKC) Approves 1.14M Share Buyback” on May 10, 2018. More interesting news about IBERIABANK Corporation (NASDAQ:IBKC) were released by: Streetinsider.com and their article: “IBERIABANK Corp. (IBKC) Appoints Rosa Sugranes to Board” published on May 09, 2018 as well as Globenewswire.com‘s news article titled: “Report: Exploring Fundamental Drivers Behind Reliance Steel & Aluminum, Goldman Sachs BDC, IBERIABANK …” with publication date: May 04, 2018.

Investors sentiment decreased to 1.16 in Q4 2017. Its down 0.22, from 1.38 in 2017Q3. It dropped, as 29 investors sold IBERIABANK Corporation shares while 65 reduced holdings. 38 funds opened positions while 71 raised stakes. 45.24 million shares or 7.84% more from 41.95 million shares in 2017Q3 were reported. Moreover, Voya Management Ltd Limited Liability Company has 0% invested in IBERIABANK Corporation (NASDAQ:IBKC) for 22,068 shares. Massachusetts-based Seaward Management Partnership has invested 0.79% in IBERIABANK Corporation (NASDAQ:IBKC). Royal State Bank Of Canada holds 406,245 shares or 0.01% of its portfolio. Georgia-based Suntrust Banks Inc has invested 0% in IBERIABANK Corporation (NASDAQ:IBKC). Mendon Cap Advsr Corp holds 0.55% of its portfolio in IBERIABANK Corporation (NASDAQ:IBKC) for 75,000 shares. Atlanta Capital Mngmt L L C invested in 0.15% or 369,403 shares. Estabrook Capital Mngmt holds 0.02% or 1,924 shares. Wellington Management Gp Ltd Liability Partnership accumulated 2.28 million shares. Comerica Bancorp invested 0.03% of its portfolio in IBERIABANK Corporation (NASDAQ:IBKC). Public Employees Retirement Association Of Colorado holds 0% or 7,456 shares. Huntington Fincl Bank reported 1,838 shares stake. Brandywine Global Management Ltd reported 0.05% of its portfolio in IBERIABANK Corporation (NASDAQ:IBKC). Vermont-based Tru Of Vermont has invested 0% in IBERIABANK Corporation (NASDAQ:IBKC). Stifel Corp has invested 0.03% of its portfolio in IBERIABANK Corporation (NASDAQ:IBKC). Fdx Advisors owns 0.01% invested in IBERIABANK Corporation (NASDAQ:IBKC) for 4,209 shares.

Among 25 analysts covering Amgen Inc. (NASDAQ:AMGN), 11 have Buy rating, 0 Sell and 14 Hold. Therefore 44% are positive. Amgen Inc. had 89 analyst reports since August 3, 2015 according to SRatingsIntel. The stock has “Overweight” rating by Morgan Stanley on Thursday, October 26. The rating was maintained by Cowen & Co on Tuesday, October 3 with “Buy”. Bank of America upgraded the shares of AMGN in report on Wednesday, February 1 to “Buy” rating. The firm has “Outperform” rating by Credit Suisse given on Wednesday, January 20. The stock of Amgen Inc. (NASDAQ:AMGN) has “Neutral” rating given on Wednesday, July 26 by UBS. The firm earned “Neutral” rating on Friday, February 2 by Credit Suisse. Jefferies maintained the shares of AMGN in report on Sunday, August 27 with “Buy” rating. The firm has “Buy” rating given on Monday, June 19 by Oppenheimer. On Thursday, September 7 the stock rating was maintained by Piper Jaffray with “Buy”. Oppenheimer maintained the stock with “Buy” rating in Monday, June 5 report.

Since December 12, 2017, it had 0 buys, and 6 selling transactions for $1.64 million activity. On Tuesday, December 12 Harper Sean E sold $269,666 worth of Amgen Inc. (NASDAQ:AMGN) or 1,525 shares.

Investors sentiment increased to 1.22 in Q4 2017. Its up 0.23, from 0.99 in 2017Q3. It increased, as 73 investors sold AMGN shares while 458 reduced holdings. 122 funds opened positions while 527 raised stakes. 551.71 million shares or 0.60% less from 555.05 million shares in 2017Q3 were reported. Rathbone Brothers Public Lc reported 0.4% in Amgen Inc. (NASDAQ:AMGN). Van Hulzen Asset Ltd Liability Co has invested 0.36% of its portfolio in Amgen Inc. (NASDAQ:AMGN). Union Bank & Trust Corp reported 0.09% stake. Walter & Keenan Consulting Mi Adv reported 0.63% in Amgen Inc. (NASDAQ:AMGN). Kentucky Retirement Sys Fund reported 0.56% of its portfolio in Amgen Inc. (NASDAQ:AMGN). Mathes holds 0.44% in Amgen Inc. (NASDAQ:AMGN) or 5,530 shares. 21,750 are owned by Alpine Woods Capital Llc. 402,853 are owned by Clarivest Asset Mgmt Ltd. Tiverton Asset Mngmt Ltd Liability Com has invested 0.1% in Amgen Inc. (NASDAQ:AMGN). 11,450 were accumulated by Tower Limited (Trc). First Manhattan Communications reported 364,390 shares or 0.35% of all its holdings. Primecap Management Co Ca holds 2.94% in Amgen Inc. (NASDAQ:AMGN) or 22.03M shares. Cadence Capital Mngmt Limited Liability Corp holds 0.77% of its portfolio in Amgen Inc. (NASDAQ:AMGN) for 69,995 shares. Smith Salley Associate has 19,795 shares. Temasek (Private) Ltd holds 0.2% or 188,527 shares.

More notable recent Amgen Inc. (NASDAQ:AMGN) news were published by: 247Wallst.com which released: “Amgen’s Novel Migraine Treatment Gets Key Approval” on May 18, 2018, also Seekingalpha.com with their article: “Expanded label for Amgen’s Repatha approved in Europe” published on May 16, 2018, Seekingalpha.com published: “Amgen’s Dim Sales Outlook Looms Over Buybacks” on April 26, 2018. More interesting news about Amgen Inc. (NASDAQ:AMGN) were released by: Fool.com and their article: “Better Buy: Amgen Inc. vs. Biogen Inc.” published on May 15, 2018 as well as Nasdaq.com‘s news article titled: “Why Spectrum Pharmaceuticals, Inc. Is Up Big Today” with publication date: May 17, 2018.

Analysts await Amgen Inc. (NASDAQ:AMGN) to report earnings on July, 24. They expect $3.52 earnings per share, up 7.65% or $0.25 from last year’s $3.27 per share. AMGN’s profit will be $2.34 billion for 12.61 P/E if the $3.52 EPS becomes a reality. After $3.47 actual earnings per share reported by Amgen Inc. for the previous quarter, Wall Street now forecasts 1.44% EPS growth.

IBERIABANK Corporation (NASDAQ:IBKC) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *